Several factors explain the lack of approval: insufficient clinical trials (no completed Phase 3 trials for most indications), safety concerns (FDA has identified specific adverse events), commercial considerations (patent status affects development investment), regulatory pathway (approval requires specific, rigorous documentation), and competition (Tesamorelin already approved for related indication)
The most common side effects include nausea, vomiting, diarrhea, constipation, and stomach discomfort
Is Zepbound a long-term treatment for weight management
GLP-1 treatment starts at the lowest dose and increases gradually over a few weeks, so theres a built-in adjustment period before you reach a full dose
Comorbidities of gout and hyperuricemia in the US general population: NHANES 2007-2008